Indication
Encephalitis due to toxoplasmosis
Encephalitis due to toxoplasmosis is an opportunistic central nervous system infection caused by the obligate intracellular protozoan parasite *Toxoplasma gondii*. Read more about Encephalitis due to toxoplasmosis
13 drugs 13 manufacturers
Drugs that treat it
Common Encephalitis due to toxoplasmosis therapies.
SULFADIAZINE
PYRIMETHAMINE
PYRIMETHAMINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEncephalitis due to toxoplasmosis is an opportunistic central nervous system infection caused by the obligate intracellular protozoan parasite *Toxoplasma gondii*.
It primarily occurs in severely immunocompromised individuals, most notably patients with advanced HIV infection or AIDS—where it serves as an AIDS-defining illness—as well as solid-organ and hematopoietic stem cell transplant recipients.
Pathophysiologically, the disease typically arises from the reactivation of latent encysted bradyzoites within brain tissue into rapidly multiplying, lytic tachyzoites when cellular immunity wanes.
Clinically, it manifests as subacute necrotizing encephalitis marked by fever, headache, altered mental status, seizures, and focal neurological deficits, characteristically presenting on neuroimaging with multiple ring-enhancing brain lesions and surrounding vasogenic edema.
- nih.gov
Encephalitis due to toxoplasmosis is an opportunistic central nervous system infection caused by the obligate intracellular protozoan parasite *Toxoplasma gondii*
- nih.gov
Encephalitis due to toxoplasmosis is an opportunistic central nervous system infection caused by the obligate intracellular protozoan parasite *Toxoplasma gondii* It primarily occurs in severely immunocompromised individuals, most notably patients with advanced HIV infection or AIDS—where it serves as an AIDS-defining illness—as well as solid-organ and hematopoietic stem cell transplant recipients Clinically, it manifests as subacute necrotizing encephalitis marked by fever, headache, altered me...
- hiv.gov
It primarily occurs in severely immunocompromised individuals, most notably patients with advanced HIV infection or AIDS—where it serves as an AIDS-defining illness—as well as solid-organ and hematopoietic stem cell transplant recipients
- nih.gov
It primarily occurs in severely immunocompromised individuals, most notably patients with advanced HIV infection or AIDS—where it serves as an AIDS-defining illness—as well as solid-organ and hematopoietic stem cell transplant recipients
- nih.gov
Pathophysiologically, the disease typically arises from the reactivation of latent encysted bradyzoites within brain tissue into rapidly multiplying, lytic tachyzoites when cellular immunity wanes
- nih.gov
Pathophysiologically, the disease typically arises from the reactivation of latent encysted bradyzoites within brain tissue into rapidly multiplying, lytic tachyzoites when cellular immunity wanes
- hiv.gov
Clinically, it manifests as subacute necrotizing encephalitis marked by fever, headache, altered mental status, seizures, and focal neurological deficits, characteristically presenting on neuroimaging with multiple ring-enhancing brain lesions and surrounding vasogenic edema
- nih.gov
Clinically, it manifests as subacute necrotizing encephalitis marked by fever, headache, altered mental status, seizures, and focal neurological deficits, characteristically presenting on neuroimaging with multiple ring-enhancing brain lesions and surrounding vasogenic edema
Personalize your experience
Follow Encephalitis due to toxoplasmosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.